478 related articles for article (PubMed ID: 9577654)
1. [Molecular genetics of Alzheimer's disease--presenilin and other genes].
Tabira T
Rinsho Shinkeigaku; 1997 Dec; 37(12):1095-6. PubMed ID: 9577654
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics of Alzheimer's disease.
Goate AM
Geriatrics; 1997 Sep; 52 Suppl 2():S9-12. PubMed ID: 9307578
[TBL] [Abstract][Full Text] [Related]
3. [Genetic factors and a polygenic model of Alzheimer's disease].
Rogaev EI
Genetika; 1999 Nov; 35(11):1558-71. PubMed ID: 10624576
[TBL] [Abstract][Full Text] [Related]
4. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
5. LDL receptor-related protein (LRP) in Alzheimer's disease: towards a unified theory of pathogenesis.
Van Uden E; Kang DE; Koo EH; Masliah E
Microsc Res Tech; 2000 Aug; 50(4):268-72. PubMed ID: 10936878
[TBL] [Abstract][Full Text] [Related]
6. [Genes in Alzheimer's disease].
Hoenicka J
Rev Neurol; 2006 Mar 1-15; 42(5):302-5. PubMed ID: 16538594
[TBL] [Abstract][Full Text] [Related]
7. Genetic study of Sardinian patients with Alzheimer's disease.
Piscopo P; Manfredi A; Malvezzi-Campeggi L; Crestini A; Spadoni O; Cherchi R; Deiana E; Piras MR; Confaloni A
Neurosci Lett; 2006 May; 398(1-2):124-8. PubMed ID: 16423463
[TBL] [Abstract][Full Text] [Related]
8. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
[TBL] [Abstract][Full Text] [Related]
9. [Alzheimer's disease. Present and future role of genetics].
Roks G
Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):13-20. PubMed ID: 12629906
[TBL] [Abstract][Full Text] [Related]
10. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland.
Zekanowski C; Styczyńska M; Pepłońska B; Gabryelewicz T; Religa D; Ilkowski J; Kijanowska-Haładyna B; Kotapka-Minc S; Mikkelsen S; Pfeffer A; Barczak A; Łuczywek E; Wasiak B; Chodakowska-Zebrowska M; Gustaw K; Łaczkowski J; Sobów T; Kuźnicki J; Barcikowska M
Exp Neurol; 2003 Dec; 184(2):991-6. PubMed ID: 14769392
[TBL] [Abstract][Full Text] [Related]
11. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.
Walker ES; Martinez M; Brunkan AL; Goate A
J Neurochem; 2005 Jan; 92(2):294-301. PubMed ID: 15663477
[TBL] [Abstract][Full Text] [Related]
12. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
13. Genetic study of familial cases of Alzheimer's disease.
Kowalska A; Pruchnik-Wolińska D; Florczak J; Modestowicz R; Szczech J; Kozubski W; Rossa G; Wender M
Acta Biochim Pol; 2004; 51(1):245-52. PubMed ID: 15094846
[TBL] [Abstract][Full Text] [Related]
14. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
15. A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes.
Gómez-Isla T; Wasco W; Pettingell WP; Gurubhagavatula S; Schmidt SD; Jondro PD; McNamara M; Rodes LA; DiBlasi T; Growdon WB; Seubert P; Schenk D; Growdon JH; Hyman BT; Tanzi RE
Ann Neurol; 1997 Jun; 41(6):809-13. PubMed ID: 9189043
[TBL] [Abstract][Full Text] [Related]
16. Genetic association of two chromosome 14 genes (presenilin 1 and alpha 1-antichymotrypsin) with Alzheimer's disease.
Wang X; DeKosky ST; Wisniewski S; Aston ; Kamboh MI
Ann Neurol; 1998 Sep; 44(3):387-90. PubMed ID: 9749607
[TBL] [Abstract][Full Text] [Related]
17. No association between the intronic presenilin 1 polymorphism and Alzheimer's disease in the Chinese population.
Wu X; Jiang S; Lin S; Tang G; Feng G; Qian Y; Wang D; Ren D; Gu N
Am J Med Genet; 1999 Feb; 88(1):1-3. PubMed ID: 10050959
[TBL] [Abstract][Full Text] [Related]
18. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease.
Mattila KM; Forsell C; Pirttilä T; Rinne JO; Lehtimäki T; Röyttä M; Lilius L; Eerola A; St George-Hyslop PH; Frey H; Lannfelt L
Ann Neurol; 1998 Dec; 44(6):965-7. PubMed ID: 9851443
[TBL] [Abstract][Full Text] [Related]
19. [Etiology and genetics of Alzheimer disease].
Myhre A; Tysnes OB
Tidsskr Nor Laegeforen; 2002 Jan; 122(1):50-3. PubMed ID: 11851296
[TBL] [Abstract][Full Text] [Related]
20. Mapping the APP/presenilin (PS) binding domains: the hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction.
Pradier L; Carpentier N; Delalonde L; Clavel N; Bock MD; Buée L; Mercken L; Tocqué B; Czech C
Neurobiol Dis; 1999 Feb; 6(1):43-55. PubMed ID: 10078972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
